- Home
- TC vs PMN Comparison
TC vs PMN Comparison
Compare TC & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- PMN
- Stock Information
- Founded
- TC 2010
- PMN 2004
- Country
- TC China
- PMN Canada
- Employees
- TC N/A
- PMN N/A
- Industry
- TC Business Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- TC Consumer Discretionary
- PMN Health Care
- Exchange
- TC Nasdaq
- PMN Nasdaq
- Market Cap
- TC 25.0M
- PMN 23.5M
- IPO Year
- TC 2018
- PMN N/A
- Fundamental
- Price
- TC $18.56
- PMN $0.38
- Analyst Decision
- TC
- PMN Strong Buy
- Analyst Count
- TC 0
- PMN 3
- Target Price
- TC N/A
- PMN $4.33
- AVG Volume (30 Days)
- TC 14.0K
- PMN 468.3K
- Earning Date
- TC 12-16-2025
- PMN 11-14-2025
- Dividend Yield
- TC N/A
- PMN N/A
- EPS Growth
- TC N/A
- PMN N/A
- EPS
- TC N/A
- PMN N/A
- Revenue
- TC $5,115,721.00
- PMN N/A
- Revenue This Year
- TC N/A
- PMN N/A
- Revenue Next Year
- TC N/A
- PMN N/A
- P/E Ratio
- TC N/A
- PMN N/A
- Revenue Growth
- TC N/A
- PMN N/A
- 52 Week Low
- TC $9.20
- PMN $0.38
- 52 Week High
- TC $39.00
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- TC 70.64
- PMN 37.11
- Support Level
- TC $16.50
- PMN $0.39
- Resistance Level
- TC $18.00
- PMN $0.48
- Average True Range (ATR)
- TC 1.29
- PMN 0.03
- MACD
- TC 0.11
- PMN -0.00
- Stochastic Oscillator
- TC 74.60
- PMN 1.22
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.